[go: up one dir, main page]

ES2443816B1 - Composición para la prevención y/o el tratamiento de la dermatosis y procedimiento de obtención del mismo - Google Patents

Composición para la prevención y/o el tratamiento de la dermatosis y procedimiento de obtención del mismo Download PDF

Info

Publication number
ES2443816B1
ES2443816B1 ES201230434A ES201230434A ES2443816B1 ES 2443816 B1 ES2443816 B1 ES 2443816B1 ES 201230434 A ES201230434 A ES 201230434A ES 201230434 A ES201230434 A ES 201230434A ES 2443816 B1 ES2443816 B1 ES 2443816B1
Authority
ES
Spain
Prior art keywords
dermatosis
prevention
procedure
obtaining
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES201230434A
Other languages
English (en)
Other versions
ES2443816A1 (es
Inventor
Juan Miguel GARCÍA GILABERT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PSORIAPIEL SALUD, S.L.
Original Assignee
PSORIAPIEL SALUD S L
PSORIAPIEL SALUD SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES201230434A priority Critical patent/ES2443816B1/es
Application filed by PSORIAPIEL SALUD S L, PSORIAPIEL SALUD SL filed Critical PSORIAPIEL SALUD S L
Priority to EP13764862.2A priority patent/EP2829276A4/en
Priority to PCT/ES2013/070178 priority patent/WO2013140009A1/es
Priority to MX2014011198A priority patent/MX2014011198A/es
Priority to CA2867907A priority patent/CA2867907A1/en
Priority to US14/386,547 priority patent/US20150056175A1/en
Priority to CN201380015140.XA priority patent/CN104203259A/zh
Priority to RU2014140541A priority patent/RU2014140541A/ru
Publication of ES2443816A1 publication Critical patent/ES2443816A1/es
Priority to DO2014000205A priority patent/DOP2014000205A/es
Priority to IL234700A priority patent/IL234700A0/en
Priority to IN8594DEN2014 priority patent/IN2014DN08594A/en
Priority to CO14231785A priority patent/CO7111265A2/es
Application granted granted Critical
Publication of ES2443816B1 publication Critical patent/ES2443816B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536—Prunella or Brunella (selfheal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Animal Husbandry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

Composición para la prevención y/o tratamiento de la dermatosis, especialmente de la psoriasis y procedimiento de obtención del mismo y que comprende manzanilla, tomillo, laurel, Lúpulo, mijo, malta de cebada, levadura de cerveza sauce, alhova (Trigoneila foenum-graecum), salicaria (Lythrum salicaria); hibisco (Hibiscus), aceite de oliva, miel de abeja, aloe vera, salvado de avena, achicoria, coparchy (Coutarea latifolia), Stevia, harina de trigo, ciprés, malta de cerveza, lanolina, sauco, vara de oro (Solidago), Hamamelis; consuelda (Prunella vulgaris), y hierba de San Juan (Hypericurn perforaturn).

Description



imagen1
imagen2
imagen3
imagen4

Claims (1)



  1. imagen1
ES201230434A 2012-03-22 2012-03-22 Composición para la prevención y/o el tratamiento de la dermatosis y procedimiento de obtención del mismo Active ES2443816B1 (es)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ES201230434A ES2443816B1 (es) 2012-03-22 2012-03-22 Composición para la prevención y/o el tratamiento de la dermatosis y procedimiento de obtención del mismo
RU2014140541A RU2014140541A (ru) 2012-03-22 2013-03-16 Композиция для профилактики и/или лечения дерматоза и способ ее получения
MX2014011198A MX2014011198A (es) 2012-03-22 2013-03-16 Composicion para la prevencion y/o tratamiento de la dermatosis y procedimiento de obtencion del mismo.
CA2867907A CA2867907A1 (en) 2012-03-22 2013-03-16 Composition for preventing and/or treating dermatosis and method for obtaining same
US14/386,547 US20150056175A1 (en) 2012-03-22 2013-03-16 Composition for preventing and/or treating dermatosis and method for obtaining same
CN201380015140.XA CN104203259A (zh) 2012-03-22 2013-03-16 用于预防和/或治疗皮肤病的组合物以及用于获得该组合物的方法
EP13764862.2A EP2829276A4 (en) 2012-03-22 2013-03-16 COMPOSITION FOR PREVENTING AND / OR TREATING DERMATOSIS AND METHOD FOR OBTAINING THE SAME
PCT/ES2013/070178 WO2013140009A1 (es) 2012-03-22 2013-03-16 Composición para la prevención y/o el tratamiento de la dermatosis y procedimiento de obtención del mismo
DO2014000205A DOP2014000205A (es) 2012-03-22 2014-09-10 Composición para la prevención y/o tratamiento de la dermatosis y procedimiento de obtención del mismo
IL234700A IL234700A0 (en) 2012-03-22 2014-09-17 A preparation for the prevention and/or treatment of a skin disease and a method for obtaining it
IN8594DEN2014 IN2014DN08594A (es) 2012-03-22 2014-10-14
CO14231785A CO7111265A2 (es) 2012-03-22 2014-10-20 Composición para la prevención y/o tratamiento de la dermatosis y procedimiento de obtención del mismo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201230434A ES2443816B1 (es) 2012-03-22 2012-03-22 Composición para la prevención y/o el tratamiento de la dermatosis y procedimiento de obtención del mismo

Publications (2)

Publication Number Publication Date
ES2443816A1 ES2443816A1 (es) 2014-02-20
ES2443816B1 true ES2443816B1 (es) 2014-12-09

Family

ID=49221884

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201230434A Active ES2443816B1 (es) 2012-03-22 2012-03-22 Composición para la prevención y/o el tratamiento de la dermatosis y procedimiento de obtención del mismo

Country Status (12)

Country Link
US (1) US20150056175A1 (es)
EP (1) EP2829276A4 (es)
CN (1) CN104203259A (es)
CA (1) CA2867907A1 (es)
CO (1) CO7111265A2 (es)
DO (1) DOP2014000205A (es)
ES (1) ES2443816B1 (es)
IL (1) IL234700A0 (es)
IN (1) IN2014DN08594A (es)
MX (1) MX2014011198A (es)
RU (1) RU2014140541A (es)
WO (1) WO2013140009A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3031455B1 (fr) * 2015-01-14 2019-12-13 Greenpharma Compose derive de l’acide gallique et applications
CN106456478A (zh) * 2014-03-18 2017-02-22 格林法马公司 没食子酸及其衍生物的化妆品和医药应用
FR3018685B1 (fr) * 2014-03-18 2019-08-09 Greenpharma Applications cosmetiques et pharmaceutiques de la salicaire
CN103926344B (zh) * 2014-04-18 2015-12-30 广州白云山星群(药业)股份有限公司 夏枯草指纹图谱的检测方法
CL2014002248A1 (es) 2014-08-25 2014-10-17 Muciderm S A Composicion farmaceutica que comprende baba de caracol helix aspersa müller (5% a 50%), extracto de manzanilla (5% a 10%) y miel (5% a 10%); procedimiento de preparacion; uso de la composicion porque sirve para preparar un medicamento o dispositivo util para prevenir o tratar lesiones derivadas de la soriasis.
ES2564560B1 (es) * 2014-09-23 2017-03-13 Agencia Pública Empresarial Sanitaria Hospital Alto Guadalquivir Composición para el alivio, mejora, prevención y/o tratamiento del síndrome de ojo seco
EP3199163A4 (en) * 2014-09-23 2018-06-20 Agencia Pública Empresarial Sanitaria Hospital Alto Guadalquivir Composition of doxycycline in liposomes for the prevention, improvement and/or treatment of ocular pathologies
CL2014002729A1 (es) * 2014-10-10 2014-12-19 Muciderm S A Composicion farmaceutica conformada por baba de caracol helix aspersa müller (20-50%), extracto de manzanilla (1-4%), propoleo (1-4%) y aditivos y/o excipientes, con una viscosidad de 10 a 1000 pa-s, en forma de locion, crema, jabon o gel; procedimiento para obtenerla; y su uso para prevenir o tratar patologias de la rosacea.
CN106421136A (zh) * 2016-11-10 2017-02-22 刘大仟 一种消炎止痒油
AU2017380471B2 (en) * 2016-12-23 2023-12-21 Mm Health Ltd Topical formulation comprising green lipped mussel and honey
WO2020021477A2 (en) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating the eye
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
AU2020255676A1 (en) * 2019-04-05 2021-11-25 Galia Saleh Formulations for treating psoriasis
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
WO2023128884A1 (en) * 2021-12-28 2023-07-06 İsti̇nye Üni̇versi̇tesi̇ Thermoreversible gel formulation with herbal active materials in order to calm and accelarate the healing of burnt skin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7241456B2 (en) * 2002-10-25 2007-07-10 Australian Importers Ltd. Formulations for topical delivery of bioactive substances and methods for their use
US20040116539A1 (en) * 2002-12-16 2004-06-17 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Late variant addition process for personal care products
US7357950B2 (en) * 2003-03-21 2008-04-15 Elizabeth Anne Mazzio Topical treatment for dyshidrosis (pompholyx) and dry skin disorders
JP2003277226A (ja) * 2003-04-18 2003-10-02 Noevir Co Ltd 皮膚外用剤
ES2315186B1 (es) * 2007-08-13 2010-01-08 Jose Ramos Prieto Pomada para combatir y tratar enfermedades de la piel, y procedimiento de preparacion de dicha pomada.
DE102009019104A1 (de) * 2009-04-29 2010-11-04 Bionorica Se Kosmetische oder dermatologische Zusammensetzung enthaltend Hydrolysate aus Pflanzenextrakten
TR200908386A2 (tr) * 2009-11-05 2010-06-21 Mci İlaç Ve Kozmeti̇k Ürünleri̇ İmalat Ti̇c. Ltd. Şti̇. Cilt yanıkları, cilt hastalıkları ve enfekte yaraların tedavisinde kullanılan dermatolojik kompozisyon

Also Published As

Publication number Publication date
CA2867907A1 (en) 2013-09-26
CN104203259A (zh) 2014-12-10
US20150056175A1 (en) 2015-02-26
IL234700A0 (en) 2014-11-30
WO2013140009A1 (es) 2013-09-26
EP2829276A4 (en) 2015-12-02
RU2014140541A (ru) 2016-05-20
IN2014DN08594A (es) 2015-05-22
CO7111265A2 (es) 2014-11-10
DOP2014000205A (es) 2015-03-31
EP2829276A1 (en) 2015-01-28
MX2014011198A (es) 2016-07-06
ES2443816A1 (es) 2014-02-20

Similar Documents

Publication Publication Date Title
ES2443816B1 (es) Composición para la prevención y/o el tratamiento de la dermatosis y procedimiento de obtención del mismo
PH12020550051B1 (en) Glp-1 compositions and uses thereof
EA023222B8 (ru) Пиразолилхиноксалиновые ингибиторы киназы
MX373318B (es) 5-bromo-2,6-di-(1h-pirazol-1-il) pirimidin-4-amina-para su uso en el tratamiento del cáncer.
MX2017007976A (es) Compuestos inhibidores de parg.
MX2017010598A (es) Hoja de acero laminada en caliente.
CL2011002056A1 (es) Compuestos derivados del acido {7-([1,2,3]triazol-1-il)-6,7,8,9-tetrahidropirido[1,2-a]indol-10-il}-acetico, antagonista del receptor crth2; composicion farmaceutica que lo comprende; utiles ene l tratamiento del asma, alergias, cancer entre otras.
WO2017091683A8 (en) Antibody molecules to april and uses thereof
TW200738709A (en) Fused heterobicyclic kinase inhibitors
ATE488232T1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
MX2011009780A (es) Pirimidinas sustituidas para el tratamiento del cancer.
MX2015007379A (es) Nuevos compuestos.
WO2014197653A3 (en) Imidazolyl progesterone antagonists
CL2013000868A1 (es) Anticuerpo aislado que se une al complejo i del citomegalovirus humano (hcmv) o al gh de hcmv; acido nucleico que lo codifica; celula huesped; metodo de produccion; composicion que lo comprende; y su uso para tratar, inhibir o prevenir la infeccion por hcmv.
PH12014501061B1 (en) Tricyclic compounds, compositions comprising them and uses thereof
WO2014186750A3 (en) Variants of tnfsf15 and dcr3 associated with crohn's disease
WO2015059463A3 (en) Treatment of beta-catenin related diseases8
CA189687S (en) Transaction card
NZ738100A (en) Igfbp3 and uses thereof
WO2022058591A3 (en) Sars-cov-2-nanobodies
WO2010030835A3 (en) Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor
TR201900959T4 (tr) Bi̇leşi̇mler ve bunlarin tibbi̇ kullanimi.
CL2008003313A1 (es) Anticuerpo anti-factor b que se une esencialmente al mismo epitope que el anticuerpo 1f7 antifactor b; composicion farmaceutica que comprende el antagonista del factor b; uso de un antagonista del factor b para prevenir o tratar afeccion ocular asociada con el complemento.
TN2017000416A1 (en) Novel pharmaceutical uses
Zhang et al. Cavernous mesenteric lymphangioma presenting as intra-abdominal malignancy

Legal Events

Date Code Title Description
PC2A Transfer of patent

Owner name: PSORIAPIEL SALUD, S.L.

Effective date: 20130710

FG2A Definitive protection

Ref document number: 2443816

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20141209

PC2A Transfer of patent

Owner name: INDALOPIEL, S.L.

Effective date: 20180308

PC2A Transfer of patent

Owner name: PSORIAPIEL SALUD, S.L.

Effective date: 20200128